Clinical Trial Detail

NCT ID NCT01811498
Title Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors North Shore Long Island Jewish Health System
Indications

glioblastoma multiforme

Therapies

Bevacizumab

Age Groups: adult

No variant requirements are available.